Theoretically, the advent of oral MS treatments was supposed to drain sales away from less-convenient injectables--and quickly. In practice, patients and doctors have proven more cautious about the newer drugs, The Wall Street Journal reports.The ease of taking a pill isn't seen as much of an advantage, at least not yet. Deciding which type of treatment to use is "all about safety and efficacy, not oral versus needle," Lawrence Steinman, a Stanford University neurologist, told the WSJ. Story